RCMI Coordinating Center (RCMI CC) Header Logo

Jose L. Lopez-Ribot

InstitutionUniversity of Texas at San Antonio
Address1 UTSA Cir
San Antonio TX 78249
Phone(210) 458-7022
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Lopez-Ribot’s lab studies fungal infections, with an emphasis on the opportunistic pathogenic fungus Candida albicans. The pathogen is capable of causing overt disease (candidiasis), but usually only in hosts with defective immunity. Candidiasis is now the third to fourth most common nosocomial, hospital-acquired, infection. Studies in the lab work to integrate "microorganism-centered" and "host-centered" facets to better understand C. albicans pathogenesis. Some of the highlights of this research program include: a) development of novel immune-based therapies to combat candidiasis, b) the role of morphogenetic conversions in the pathogenesis of candidiasis, and c) the study of C. albicans biofilms.
    Other areas of interest in Dr. Lopez-Ribot’s lab include genomics and proteomics, cell wall and adhesion, antifungal drug resistance, development of diagnostic techniques for candidiasis, and high throughput screening for antifungal drug discovery. Main projects in the lab deal with targeting virulence factors, more specifically filamentation and biofilm formation, for the development of novel antifungal agents, and with developing microbial chips as a new universal technology platform for microbial culture at the nanoscale level.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wall G, Chen E, Hull MV, Lopez-Ribot JL. Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Front Cell Infect Microbiol. 2020; 10:597931. PMID: 33324579.
      Citations:    Fields:    
    2. Vazquez-Munoz R, Arellano-Jimenez MJ, Lopez-Ribot JL. Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans. BMC Biomed Eng. 2020; 2:11. PMID: 33073175.
    3. Lara HH, Lopez-Ribot JL. Inhibition of Mixed Biofilms of Candida albicans and Methicillin-Resistant Staphylococcus aureus by Positively Charged Silver Nanoparticles and Functionalized Silicone Elastomers. Pathogens. 2020 Sep 25; 9(10). PMID: 32992727.
    4. Wall G, Lopez-Ribot JL. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrob Agents Chemother. 2020 08 20; 64(9). PMID: 32660991.
      Citations: 2     Fields:    
    5. Vazquez-Munoz R, Lopez FD, Lopez-Ribot JL. Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic Yeast Candida auris. Antibiotics (Basel). 2020 Jul 29; 9(8). PMID: 32751405.
    6. Vazquez-Munoz R, Lopez FD, Lopez-Ribot JL. Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions. Front Microbiol. 2020; 11:1673. PMID: 32849347.
    7. Wall G, Lopez-Ribot JL. Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics (Basel). 2020 Jul 25; 9(8). PMID: 32722455.
    8. Mei Y, Jiang T, Zou Y, Wang Y, Zhou J, Li J, Liu L, Tan J, Wei L, Li J, Dai H, Peng Y, Zhang L, Lopez-Ribot JL, Shapiro RS, Chen C, Liu NN, Wang H. FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal. Front Microbiol. 2020; 11:996. PMID: 32582050.
    9. Campuzano A, Zhang H, Ostroff GR, Dos Santos Dias L, Wüthrich M, Klein BS, Yu JJ, Lara HH, Lopez-Ribot JL, Hung CY. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against Coccidioides posadasii Infection. J Immunol. 2020 06 15; 204(12):3296-3306. PMID: 32358020.
      Citations: 5     Fields:    Translation:AnimalsCells
    10. Vazquez-Munoz R, Arellano-Jimenez MJ, Lopez-Ribot JL. Fast, facile synthesis method for BAL-mediated PVP-bismuth nanoparticles. MethodsX. 2020; 7:100894. PMID: 32405464.
    11. Lara HH, Ixtepan-Turrent L, Jose Yacaman M, Lopez-Ribot J. Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles. ACS Appl Mater Interfaces. 2020 May 13; 12(19):21183-21191. PMID: 31944650.
      Citations: 10     Fields:    Translation:Animals
    12. Lara HH, Black DM, Moon C, Orr E, Lopez P, Alvarez MM, Baghdasarian G, Lopez-Ribot J, Whetten RL. Activating a Silver Lipoate Nanocluster with a Penicillin Backbone Induces a Synergistic Effect against S. aureus Biofilm. ACS Omega. 2019 Dec 24; 4(26):21914-21920. PMID: 31891070.
    13. Vazquez-Muñoz R, Arellano-Jimenez MJ, Lopez FD, Lopez-Ribot JL. Protocol optimization for a fast, simple and economical chemical reduction synthesis of antimicrobial silver nanoparticles in non-specialized facilities. BMC Res Notes. 2019 Nov 27; 12(1):773. PMID: 31775864.
      Citations: 5     Fields:    Translation:AnimalsCells
    14. Banerjee M, Lazzell AL, Romo JA, Lopez-Ribot JL, Kadosh D. Filamentation Is Associated with Reduced Pathogenicity of Multiple Non-albicans Candida Species. mSphere. 2019 10 16; 4(5). PMID: 31619502.
      Citations: 2     Fields:    Translation:Animals
    15. Romo JA, Zhang H, Cai H, Kadosh D, Koehler JR, Saville SP, Wang Y, Lopez-Ribot JL. Global Transcriptomic Analysis of the Candida albicans Response to Treatment with a Novel Inhibitor of Filamentation. mSphere. 2019 09 11; 4(5). PMID: 31511371.
      Citations: 6     Fields:    Translation:AnimalsCells
    16. Montelongo-Jauregui D, Saville SP, Lopez-Ribot JL. Contributions of Candida albicans Dimorphism, Adhesive Interactions, and Extracellular Matrix to the Formation of Dual-Species Biofilms with Streptococcus gordonii. mBio. 2019 06 18; 10(3). PMID: 31213561.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    17. Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol. 2019 12; 52:1-6. PMID: 31085405.
      Citations: 14     Fields:    Translation:HumansAnimals
    18. Montelongo-Jauregui D, Lopez-Ribot JL. Candida Interactions with the Oral Bacterial Microbiota. J Fungi (Basel). 2018 Nov 03; 4(4). PMID: 30400279.
    19. Torres NS, Montelongo-Jauregui D, Abercrombie JJ, Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK, Leung KP. Antimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against Pseudomonas aeruginosa. Front Microbiol. 2018; 9:2541. PMID: 30410476.
    20. Dekkerová J, Lopez-Ribot JL, Bujdáková H. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen. Eur J Clin Microbiol Infect Dis. 2019 Jan; 38(1):101-108. PMID: 30327897.
      Citations: 3     Fields:    Translation:Animals
    21. Liu NN, Uppuluri P, Broggi A, Besold A, Ryman K, Kambara H, Solis N, Lorenz V, Qi W, Acosta-Zaldívar M, Emami SN, Bao B, An D, Bonilla FA, Sola-Visner M, Filler SG, Luo HR, Engström Y, Ljungdahl PO, Culotta VC, Zanoni I, Lopez-Ribot JL, Köhler JR. Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulence. PLoS Pathog. 2018 07; 14(7):e1007076. PMID: 30059535.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    22. Romo JA, Pierce CG, Esqueda M, Hung CY, Saville SP, Lopez-Ribot JL. In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation. Front Cell Infect Microbiol. 2018; 8:227. PMID: 30042929.
      Citations: 4     Fields:    Translation:HumansAnimals
    23. Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. Microb Cell. 2018 06 14; 5(7):300-326. PMID: 29992128.
    24. Montelongo-Jauregui D, Srinivasan A, Ramasubramanian AK, Lopez-Ribot JL. An In Vitro Model for Candida albicans?Streptococcus gordonii Biofilms on Titanium Surfaces. J Fungi (Basel). 2018 Jun 04; 4(2). PMID: 29866990.
    25. Lara HH, Guisbiers G, Mendoza J, Mimun LC, Vincent BA, Lopez-Ribot JL, Nash KL. Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms. Int J Nanomedicine. 2018; 13:2697-2708. PMID: 29760550.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    26. Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. mBio. 2017 Dec 05; 8(6). PMID: 29208749.
      Citations: 22     Fields:    Translation:Animals
    27. Srinivasan A, Lee GC, Torres NS, Hernandez K, Dallas SD, Lopez-Ribot J, Frei CR, Ramasubramanian AK. High-throughput microarray for antimicrobial susceptibility testing. Biotechnol Rep (Amst). 2017 Dec; 16:44-47. PMID: 29167758.
    28. Srinivasan A, Torres NS, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications. mSphere. 2017 May-Jun; 2(3). PMID: 28680970.
      Citations: 4     Fields:    
    29. Pierce CG, Vila T, Romo JA, Montelongo-Jauregui D, Wall G, Ramasubramanian A, Lopez-Ribot JL. The Candida albicans Biofilm Matrix: Composition, Structure and Function. J Fungi (Basel). 2017 Mar; 3(1). PMID: 28516088.
    30. Vila T, Lopez-Ribot JL. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors. Antimicrob Agents Chemother. 2017 01; 61(1). PMID: 27795383.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    31. Torres NS, Abercrombie JJ, Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK, Leung KP. Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms. Antimicrob Agents Chemother. 2016 10; 60(10):5663-72. PMID: 27401577.
      Citations: 13     Fields:    Translation:Cells
    32. Wiederhold NP, Patterson TF, Srinivasan A, Chaturvedi AK, Fothergill AW, Wormley FL, Ramasubramanian AK, Lopez-Ribot JL. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi. Virulence. 2017 02 17; 8(2):138-142. PMID: 27268469.
      Citations: 19     Fields:    Translation:HumansAnimals
    33. Vila T, Romo JA, Pierce CG, McHardy SF, Saville SP, Lopez-Ribot JL. Targeting Candida albicans filamentation for antifungal drug development. Virulence. 2017 02 17; 8(2):150-158. PMID: 27268130.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    34. Montelongo-Jauregui D, Srinivasan A, Ramasubramanian AK, Lopez-Ribot JL. An In Vitro Model for Oral Mixed Biofilms of Candida albicans and Streptococcus gordonii in Synthetic Saliva. Front Microbiol. 2016; 7:686. PMID: 27242712.
    35. Uppuluri P, Lopez-Ribot JL. Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms. PLoS Pathog. 2016 Feb; 12(2):e1005397. PMID: 26891125.
      Citations: 11     Fields:    Translation:HumansAnimals
    36. Cleary IA, Reinhard SM, Lazzell AL, Monteagudo C, Thomas DP, Lopez-Ribot JL, Saville SP. Examination of the pathogenic potential of Candida albicans filamentous cells in an animal model of haematogenously disseminated candidiasis. FEMS Yeast Res. 2016 Mar; 16(2):fow011. PMID: 26851404.
      Citations: 2     Fields:    Translation:Animals
    37. Romero-Urbina DG, Lara HH, Velázquez-Salazar JJ, Arellano-Jiménez MJ, Larios E, Srinivasan A, Lopez-Ribot JL, Yacamán MJ. Ultrastructural changes in methicillin-resistant Staphylococcus aureus induced by positively charged silver nanoparticles. Beilstein J Nanotechnol. 2015; 6:2396-405. PMID: 26734530.
    38. Lara HH, Romero-Urbina DG, Pierce C, Lopez-Ribot JL, Arellano-Jiménez MJ, Jose-Yacaman M. Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study. J Nanobiotechnology. 2015 Dec 15; 13:91. PMID: 26666378.
      Citations: 37     Fields:    Translation:Animals
    39. Vila TV, Chaturvedi AK, Rozental S, Lopez-Ribot JL. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. Antimicrob Agents Chemother. 2015 Dec; 59(12):7611-20. PMID: 26416861.
      Citations: 19     Fields:    Translation:Animals
    40. Pierce CG, Chaturvedi AK, Lazzell AL, Powell AT, Saville SP, McHardy SF, Lopez-Ribot JL. A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance. NPJ Biofilms Microbiomes. 2015; 1. PMID: 26691764.
      Citations: 39     Fields:    
    41. Actis L, Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK, Ong JL. Effect of silver nanoparticle geometry on methicillin susceptible and resistant Staphylococcus aureus, and osteoblast viability. J Mater Sci Mater Med. 2015 Jul; 26(7):215. PMID: 26194976.
      Citations: 6     Fields:    Translation:HumansCells
    42. Pierce CG, Srinivasan A, Ramasubramanian AK, López-Ribot JL. From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms. Microbiol Spectr. 2015 Jun; 3(3). PMID: 26185082.
      Citations: 6     Fields:    Translation:HumansAnimals
    43. Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK. Microscale microbial culture. Future Microbiol. 2015; 10(2):143-6. PMID: 25689525.
      Citations: 2     Fields:    
    44. Albataineh MT, Lazzell A, Lopez-Ribot JL, Kadosh D. Ppg1, a PP2A-type protein phosphatase, controls filament extension and virulence in Candida albicans. Eukaryot Cell. 2014 Dec; 13(12):1538-47. PMID: 25326520.
      Citations: 4     Fields:    Translation:AnimalsCells
    45. Lopez-Ribot JL. Large-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights. mBio. 2014 Sep 09; 5(5):e01781-14. PMID: 25205098.
      Citations: 10     Fields:    
    46. Chaturvedi AK, Hameed RS, Wozniak KL, Hole CR, Leopold Wager CM, Weintraub ST, Lopez-Ribot JL, Wormley FL. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 2014; 9(8):e104316. PMID: 25119981.
      Citations: 16     Fields:    Translation:Animals
    47. Pierce CG, Saville SP, Lopez-Ribot JL. High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation. Pathog Dis. 2014 Apr; 70(3):423-31. PMID: 24623598.
      Citations: 12     Fields:    Translation:HumansAnimals
    48. Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK. Overcoming antifungal resistance. Drug Discov Today Technol. 2014 Mar; 11:65-71. PMID: 24847655.
      Citations: 17     Fields:    Translation:Humans
    49. Chaturvedi AK, Weintraub ST, Lopez-Ribot JL, Wormley FL. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics. 2013 Dec; 13(23-24):3429-41. PMID: 24170628.
      Citations: 13     Fields:    Translation:AnimalsCellsPHPublic Health
    50. Kadosh D, Lopez-Ribot JL. Candida albicans: adapting to succeed. . 2013 Nov 13; 14(5):483-5. PMID: 24237692.
    51. Sarkar S, Uppuluri P, Pierce CG, Lopez-Ribot JL. In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms. Antimicrob Agents Chemother. 2014; 58(2):1183-6. PMID: 24217700.
      Citations: 12     Fields:    Translation:Animals
    52. Srinivasan A, Gupta CM, Agrawal CM, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms. Biotechnol Bioeng. 2014 Feb; 111(2):418-24. PMID: 24114441.
      Citations: 3     Fields:    Translation:AnimalsCells
    53. Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, López-Ribot JL. Antifungal therapy with an emphasis on biofilms. Curr Opin Pharmacol. 2013 Oct; 13(5):726-30. PMID: 24011516.
      Citations: 41     Fields:    Translation:HumansAnimals
    54. Srinivasan A, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. High-throughput nano-biofilm microarray for antifungal drug discovery. mBio. 2013 Jun 25; 4(4). PMID: 23800397.
      Citations: 16     Fields:    Translation:HumansAnimals
    55. Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 2013 Sep; 8(9):1117-26. PMID: 23738751.
      Citations: 40     Fields:    Translation:HumansAnimals
    56. Siles SA, Srinivasan A, Pierce CG, Lopez-Ribot JL, Ramasubramanian AK. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors. Antimicrob Agents Chemother. 2013 Aug; 57(8):3681-7. PMID: 23689719.
      Citations: 35     Fields:    Translation:Animals
    57. Banerjee M, Uppuluri P, Zhao XR, Carlisle PL, Vipulanandan G, Villar CC, López-Ribot JL, Kadosh D. Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms. Eukaryot Cell. 2013 Feb; 12(2):224-32. PMID: 23223035.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    58. Uppuluri P, Chaturvedi AK, Jani N, Pukkila-Worley R, Monteagudo C, Mylonakis E, Köhler JR, Lopez Ribot JL. Physiologic expression of the Candida albicans pescadillo homolog is required for virulence in a murine model of hematogenously disseminated candidiasis. Eukaryot Cell. 2012 Dec; 11(12):1552-6. PMID: 23104566.
      Citations: 3     Fields:    Translation:Animals
    59. Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK. Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening. J Vis Exp. 2012 Jul 18; (65):e3845. PMID: 22847237.
      Citations: 5     Fields:    Translation:Animals
    60. Chambers JP, Yu JJ, Jupelli M, Weintraub ST, Lopez-Ribot JL, Valdes JJ, Arulanandam BP. Alpha-1 antitrypsin is markedly decreased following pulmonary F. tularensis challenge. Front Cell Infect Microbiol. 2011; 1:20. PMID: 22919586.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    61. Martins M, Lazzell AL, Lopez-Ribot JL, Henriques M, Oliveira R. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis. J Basic Microbiol. 2012 Aug; 52(4):487-91. PMID: 22052380.
      Citations: 7     Fields:    Translation:Animals
    62. Dahlan AA, Haveman CW, Ramage G, Lopez-Ribot JL, Redding SW. Sodium hypochlorite, chlorhexidine gluconate, and commercial denture cleansers as disinfecting agents against Candida albicans: An in vitro comparison study. Gen Dent. 2011 Nov-Dec; 59(6):e224-9. PMID: 22313927.
      Citations:    Fields:    Translation:HumansAnimals
    63. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 2011 Sep; 7(9):e1002257. PMID: 21931556.
      Citations: 95     Fields:    Translation:Animals
    64. Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses. 2012 Jan; 55(1):80-5. PMID: 21668524.
      Citations: 50     Fields:    Translation:AnimalsCells
    65. Chaturvedi AK, Lazzell AL, Saville SP, Wormley FL, Monteagudo C, Lopez-Ribot JL. Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease. PLoS One. 2011; 6(5):e20449. PMID: 21633704.
      Citations: 3     Fields:    Translation:AnimalsCells
    66. Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob Agents Chemother. 2011 Jul; 55(7):3591-3. PMID: 21518839.
      Citations: 26     Fields:    Translation:Animals
    67. Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK. Development of a high-throughput Candida albicans biofilm chip. PLoS One. 2011 Apr 22; 6(4):e19036. PMID: 21544190.
      Citations: 20     Fields:    Translation:Animals
    68. Uppuluri P, Lopez-Ribot JL. An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. Virulence. 2010 Nov-Dec; 1(6):483-7. PMID: 21178492.
      Citations: 13     Fields:    Translation:Animals
    69. Pierce CG, Uppuluri P, Tummala S, Lopez-Ribot JL. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J Vis Exp. 2010 Oct 21; (44). PMID: 21048668.
      Citations: 27     Fields:    Translation:Animals
    70. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL. The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot Cell. 2010 Oct; 9(10):1531-7. PMID: 20709787.
      Citations: 38     Fields:    Translation:Animals
    71. Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, Köhler JR, Kadosh D, Lopez-Ribot JL. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 2010 Mar 26; 6(3):e1000828. PMID: 20360962.
      Citations: 152     Fields:    Translation:HumansAnimalsCells
    72. Martins M, Uppuluri P, Thomas DP, Cleary IA, Henriques M, Lopez-Ribot JL, Oliveira R. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia. 2010 May; 169(5):323-31. PMID: 20012895.
      Citations: 65     Fields:    Translation:AnimalsCells
    73. Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol. 2009 Dec; 4(10):1235-7. PMID: 19995182.
      Citations: 23     Fields:    Translation:HumansAnimals
    74. Thomas DP, Lopez-Ribot JL, Lee SA. A proteomic analysis of secretory proteins of a pre-vacuolar mutant of Candida albicans. J Proteomics. 2009 Dec 01; 73(2):342-51. PMID: 19819358.
      Citations: 7     Fields:    Translation:AnimalsCells
    75. Uppuluri P, Dinakaran H, Thomas DP, Chaturvedi AK, Lopez-Ribot JL. Characteristics of Candida albicans biofilms grown in a synthetic urine medium. J Clin Microbiol. 2009 Dec; 47(12):4078-83. PMID: 19794044.
      Citations: 21     Fields:    Translation:HumansAnimals
    76. Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother. 2009 Sep; 64(3):567-70. PMID: 19584104.
      Citations: 38     Fields:    Translation:Animals
    77. Grubb SE, Murdoch C, Sudbery PE, Saville SP, Lopez-Ribot JL, Thornhill MH. Adhesion of Candida albicans to endothelial cells under physiological conditions of flow. Infect Immun. 2009 Sep; 77(9):3872-8. PMID: 19581400.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    78. Redding S, Bhatt B, Rawls HR, Siegel G, Scott K, Lopez-Ribot J. Inhibition of Candida albicans biofilm formation on denture material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 May; 107(5):669-72. PMID: 19426921.
      Citations: 26     Fields:    Translation:Animals
    79. Uppuluri P, Chaturvedi AK, Lopez-Ribot JL. Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance. Mycopathologia. 2009 Sep; 168(3):101-9. PMID: 19370400.
      Citations: 32     Fields:    Translation:Animals
    80. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis. Clin Vaccine Immunol. 2009 Mar; 16(3):430-2. PMID: 19144791.
      Citations: 15     Fields:    Translation:AnimalsCells
    81. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol. 2009; 35(4):340-55. PMID: 19863383.
      Citations: 128     Fields:    Translation:HumansAnimals
    82. Carlisle PL, Banerjee M, Lazzell A, Monteagudo C, López-Ribot JL, Kadosh D. Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc Natl Acad Sci U S A. 2009 Jan 13; 106(2):599-604. PMID: 19116272.
      Citations: 96     Fields:    Translation:AnimalsCells
    83. Pierce CG, Thomas DP, López-Ribot JL. Effect of tunicamycin on Candida albicans biofilm formation and maintenance. J Antimicrob Chemother. 2009 Mar; 63(3):473-9. PMID: 19098294.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    84. Lee SA, Jones J, Hardison S, Kot J, Khalique Z, Bernardo SM, Lazzell A, Monteagudo C, Lopez-Ribot J. Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence. Mycopathologia. 2009 Feb; 167(2):55-63. PMID: 18814053.
      Citations: 12     Fields:    Translation:HumansAnimals
    85. Grubb SE, Murdoch C, Sudbery PE, Saville SP, Lopez-Ribot JL, Thornhill MH. Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect Immun. 2008 Oct; 76(10):4370-7. PMID: 18573891.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    86. Ramage G, Wickes BL, López-Ribot JL. A seed and feed model for the formation of Candida albicans biofilms under flow conditions using an improved modified Robbins device. Rev Iberoam Micol. 2008 Mar; 25(1):37-40. PMID: 18338926.
      Citations: 18     Fields:    Translation:Animals
    87. Banerjee M, Thompson DS, Lazzell A, Carlisle PL, Pierce C, Monteagudo C, López-Ribot JL, Kadosh D. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell. 2008 Apr; 19(4):1354-65. PMID: 18216277.
      Citations: 91     Fields:    Translation:HumansAnimals
    88. Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008; 3(9):1494-500. PMID: 18772877.
      Citations: 235     Fields:    Translation:Animals
    89. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL. Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect Immun. 2008 Jan; 76(1):97-102. PMID: 17967861.
      Citations: 19     Fields:    Translation:Animals
    90. Ramage G, Wickes BL, López-Ribot JL. Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia. 2007 Dec; 164(6):301-6. PMID: 17909983.
      Citations: 11     Fields:    Translation:HumansAnimals
    91. Thomas DP, Pitarch A, Monteoliva L, Gil C, Lopez-Ribot JL. Proteomics to study Candida albicans biology and pathogenicity. Infect Disord Drug Targets. 2006 Dec; 6(4):335-41. PMID: 17168799.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    92. Thomas DP, Bachmann SP, Lopez-Ribot JL. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics. 2006 Nov; 6(21):5795-804. PMID: 17001605.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    93. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006 Nov; 6(7):979-86. PMID: 17042747.
      Citations: 152     Fields:    Translation:HumansAnimals
    94. Thomas DP, Viudes A, Monteagudo C, Lazzell AL, Saville SP, López-Ribot JL. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics. 2006 Nov; 6(22):6033-41. PMID: 17051645.
      Citations: 9     Fields:    Translation:AnimalsPHPublic Health
    95. Pérez A, Pedrós B, Murgui A, Casanova M, López-Ribot JL, Martínez JP. Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain. FEMS Yeast Res. 2006 Nov; 6(7):1074-84. PMID: 17042757.
      Citations: 31     Fields:    Translation:AnimalsCells
    96. Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, Monteagudo C, Lopez-Ribot JL, Milne GT. Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother. 2006 Oct; 50(10):3312-6. PMID: 17005810.
      Citations: 47     Fields:    Translation:Animals
    97. Saville SP, Thomas DP, López Ribot JL. A role for Efg1p in Candida albicans interactions with extracellular matrices. FEMS Microbiol Lett. 2006 Mar; 256(1):151-8. PMID: 16487333.
      Citations: 11     Fields:    Translation:AnimalsCells
    98. Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis. 2006 Apr 01; 193(7):1014-22. PMID: 16518764.
      Citations: 47     Fields:    Translation:Animals
    99. Saville SP, Thomas DP, López-Ribot JL. Use of genome information for the study of the pathogenesis of fungal infections and the development of diagnostic tools. Rev Iberoam Micol. 2005 Dec; 22(4):238-41. PMID: 16499417.
      Citations: 3     Fields:    Translation:Humans
    100. Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G. Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico. J Clin Microbiol. 2005 Aug; 43(8):4159-62. PMID: 16081965.
      Citations: 8     Fields:    Translation:HumansAnimals
    101. López-Ribot JL. Candida albicans biofilms: more than filamentation. Curr Biol. 2005 Jun 21; 15(12):R453-5. PMID: 15964263.
      Citations: 40     Fields:    Translation:HumansAnimals
    102. Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Rev Iberoam Micol. 2005 Jun; 22(2):83-92. PMID: 16107165.
      Citations: 9     Fields:    Translation:HumansAnimals
    103. Ramage G, Saville SP, Thomas DP, López-Ribot JL. Candida biofilms: an update. Eukaryot Cell. 2005 Apr; 4(4):633-8. PMID: 15821123.
      Citations: 200     Fields:    Translation:Animals
    104. Ramage G, López-Ribot JL. Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med. 2005; 118:71-9. PMID: 15888936.
      Citations: 38     Fields:    Translation:Animals
    105. López-Ribot JL, Casanova M, Murgui A, Martínez JP. Antibody response to Candida albicans cell wall antigens. FEMS Immunol Med Microbiol. 2004 Jul 01; 41(3):187-96. PMID: 15196567.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    106. Ramage G, Tomsett K, Wickes BL, López-Ribot JL, Redding SW. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jul; 98(1):53-9. PMID: 15243471.
      Citations: 80     Fields:    Translation:HumansAnimals
    107. Monteagudo C, Viudes A, Lazzell A, Martinez JP, Lopez-Ribot JL. Tissue invasiveness and non-acidic pH in human candidiasis correlate with "in vivo" expression by Candida albicans of the carbohydrate epitope recognised by new monoclonal antibody 1H4. J Clin Pathol. 2004 Jun; 57(6):598-603. PMID: 15166263.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    108. Ullmann BD, Myers H, Chiranand W, Lazzell AL, Zhao Q, Vega LA, Lopez-Ribot JL, Gardner PR, Gustin MC. Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot Cell. 2004 Jun; 3(3):715-23. PMID: 15189992.
      Citations: 48     Fields:    Translation:AnimalsCells
    109. Hernandez S, López-Ribot JL, Najvar LK, McCarthy DI, Bocanegra R, Graybill JR. Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob Agents Chemother. 2004 Apr; 48(4):1382-3. PMID: 15047549.
      Citations: 64     Fields:    Translation:HumansAnimals
    110. Viudes A, Lazzell A, Perea S, Kirkpatrick WR, Peman J, Patterson TF, Martinez JP, López-Ribot JL. The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis. FEMS Microbiol Lett. 2004 Mar 19; 232(2):133-8. PMID: 15033231.
      Citations: 11     Fields:    Translation:AnimalsCells
    111. Li X, Brown N, Chau AS, López-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. J Antimicrob Chemother. 2004 Jan; 53(1):74-80. PMID: 14657086.
      Citations: 34     Fields:    Translation:HumansAnimals
    112. Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, López-Ribot JL. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother. 2003 Nov; 47(11):3657-9. PMID: 14576141.
      Citations: 33     Fields:    Translation:Animals
    113. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell. 2003 Oct; 2(5):1053-60. PMID: 14555488.
      Citations: 271     Fields:    Translation:AnimalsCells
    114. Redding SW, Kirkpatrick WR, Saville S, Coco BJ, White W, Fothergill A, Rinaldi M, Eng T, Patterson TF, Lopez-Ribot J. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol. 2003 Feb; 41(2):619-22. PMID: 12574256.
      Citations: 29     Fields:    Translation:HumansAnimalsPHPublic Health
    115. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, López-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother. 2002 Nov; 46(11):3634-6. PMID: 12384379.
      Citations: 71     Fields:    Translation:Animals
    116. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, López-Ribot JL. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002 Nov; 46(11):3591-6. PMID: 12384370.
      Citations: 97     Fields:    Translation:Animals
    117. Ramage G, Saville SP, Wickes BL, López-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002 Nov; 68(11):5459-63. PMID: 12406738.
      Citations: 196     Fields:    Translation:Animals
    118. Viudes A, Pemán J, Cantón E, Ubeda P, López-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis. 2002 Nov; 21(11):767-74. PMID: 12461585.
      Citations: 80     Fields:    Translation:HumansAnimals
    119. Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol. 2002 Sep; 40(9):3135-9. PMID: 12202543.
      Citations: 22     Fields:    Translation:HumansAnimals
    120. Ramage G, VandeWalle K, López-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett. 2002 Aug 27; 214(1):95-100. PMID: 12204378.
      Citations: 132     Fields:    Translation:Animals
    121. Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother. 2002 Jun; 46(6):1695-703. PMID: 12019078.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    122. Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002 Jun; 49(6):973-80. PMID: 12039889.
      Citations: 144     Fields:    Translation:Animals
    123. Bachmann SP, Patterson TF, López-Ribot JL. In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol. 2002 Jun; 40(6):2228-30. PMID: 12037093.
      Citations: 31     Fields:    Translation:HumansAnimals
    124. Viudes A, Pemán J, Cantón E, Salavert M, Ubeda P, López-Ribot JL, Gobernado M. Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis. 2002 Apr; 21(4):294-9. PMID: 12072941.
      Citations: 4     Fields:    Translation:HumansAnimals
    125. Martínez M, López-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, Ruesga MT, Patterson TF. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother. 2002 Mar; 49(3):515-24. PMID: 11864952.
      Citations: 16     Fields:    Translation:HumansAnimals
    126. Viudes A, Cantón E, Pemán J, López-Ribot JL, Gobernado M. [Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis]. Rev Esp Quimioter. 2002 Mar; 15(1):32-42. PMID: 12582435.
      Citations:    Fields:    Translation:Humans
    127. Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001 Dec; 18(4):163-70. PMID: 15496122.
      Citations: 106     Fields:    
    128. Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001 Oct; 45(10):2676-84. PMID: 11557454.
      Citations: 154     Fields:    Translation:HumansAnimals
    129. Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001 Sep; 45(9):2475-9. PMID: 11502517.
      Citations: 225     Fields:    Translation:HumansAnimals
    130. Ramage G, Vande Walle K, Wickes BL, López-Ribot JL. Biofilm formation by Candida dubliniensis. J Clin Microbiol. 2001 Sep; 39(9):3234-40. PMID: 11526156.
      Citations: 37     Fields:    Translation:HumansAnimals
    131. Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab. 2001 Aug; 20(7):42-4. PMID: 11570274.
      Citations: 31     Fields:    Translation:Animals
    132. Redding SW, Bailey CW, Lopez-Ribot JL, Kirkpatrick WR, Fothergill AW, Rinaldi MG, Patterson TF. Candida dubliniensis in radiation-induced oropharyngeal candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun; 91(6):659-62. PMID: 11402278.
      Citations: 7     Fields:    Translation:HumansAnimalsPHPublic Health
    133. Viudes A, Perea S, Lopez-Ribot JL. Identification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens. Infect Immun. 2001 May; 69(5):2909-19. PMID: 11292706.
      Citations: 13     Fields:    Translation:AnimalsCells
    134. Quindós G, Ezkurra P, Bikandi J, Alonso-Vargas R, Campbell C, Elguezábal N, Hallett D, López-Ribot JL, San-Millán R, Tellaetxe M. The new millennium's crossroad: where are we going? Rev Iberoam Micol. 2000 Dec; 17(4):113-5. PMID: 15762804.
      Citations:    Fields:    
    135. López-Ribot JL, McAtee RK, Kirkpatrick WR, Perea S, Patterson TF. Comparison of DNA-based typing methods to assess genetic diversity and relatedness among Candida albicans clinical isolates. Rev Iberoam Micol. 2000 Jun; 17(2):49-54. PMID: 15813695.
      Citations: 6     Fields:    
    136. Kirkpatrick WR, Lopez-Ribot JL, McAtee RK, Patterson TF. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions. J Clin Microbiol. 2000 Feb; 38(2):902-4. PMID: 10655413.
      Citations: 9     Fields:    Translation:HumansAnimals
    137. Monteagudo C, Lopez-Ribot JL, Murgui A, Casanova M, Chaffin WL, Martinez JP. Immunodetection of CD45 epitopes on the surface of Candida albicans cells in culture and infected human tissues. Am J Clin Pathol. 2000 Jan; 113(1):59-63. PMID: 10631858.
      Citations: 1     Fields:    Translation:HumansAnimals
    138. Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fothergill AW, Lopez-Ribot JL, Bailey CW, Rinaldi MG, Patterson TF. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol. 1999 Dec; 37(12):3896-900. PMID: 10565903.
      Citations: 56     Fields:    Translation:Animals
    139. Lopez-Ribot JL, McAtee RK, Kirkpatrick WR, La Valle R, Patterson TF. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Clin Diagn Lab Immunol. 1999 Sep; 6(5):665-70. PMID: 10473514.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    140. Lopez-Ribot JL, McAtee RK, Perea S, Kirkpatrick WR, Rinaldi MG, Patterson TF. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1999 Jul; 43(7):1621-30. PMID: 10390213.
      Citations: 26     Fields:    Translation:HumansAnimals
    141. López-Ribot JL, Martínez JP, Monteagudo C, Alloush HM, Mattioli NV, Chaffin WL. Evidence for the presence of complex carbohydrates in Candida albicans cell wall glycoproteins. Rev Iberoam Micol. 1999 Mar; 16(1):23-6. PMID: 18473587.
      Citations: 3     Fields:    
    142. Lopez-Ribot JL, McAtee RK, Lee LN, Kirkpatrick WR, White TC, Sanglard D, Patterson TF. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother. 1998 Nov; 42(11):2932-7. PMID: 9797228.
      Citations: 81     Fields:    Translation:HumansAnimals
    143. Kirkpatrick WR, Revankar SG, Mcatee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, Sanche SE, Cantu RA, Rinaldi MG, Patterson TF. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates. J Clin Microbiol. 1998 Oct; 36(10):3007-12. PMID: 9738058.
      Citations: 58     Fields:    Translation:HumansAnimals
    144. López-Ribot JL, Kirkpatrick WR, McAtee RK, Revankar SG, Patterson TF. Cell wall proteinaceous components in isolates of Candida albicans and non-albicans species from HIV-infected patients with oropharyngeal candidiasis. Rev Iberoam Micol. 1998 Sep; 15(3):125-30. PMID: 18473531.
      Citations:    Fields:    
    145. Gil ML, Peñalver MC, Lopez-Ribot JL, O'Connor JE, Martinez JP. Binding of extracellular matrix proteins to Aspergillus fumigatus conidia. Infect Immun. 1996 Dec; 64(12):5239-47. PMID: 8945572.
      Citations: 18     Fields:    Translation:AnimalsCells
    146. Sepulveda P, Lopez-Ribot JL, Gozalbo D, Cervera A, Martinez JP, Chaffin WL. Ubiquitin-like epitopes associated with Candida albicans cell surface receptors. Infect Immun. 1996 Oct; 64(10):4406-8. PMID: 8926122.
      Citations: 6     Fields:    Translation:AnimalsCells
    147. Sepulveda P, Cervera AM, Lopez-Ribot JL, Chaffin WL, Martinez JP, Gozalbo D. Cloning and characterization of a cDNA coding for Candida albicans polyubiquitin. J Med Vet Mycol. 1996 Sep-Oct; 34(5):315-22. PMID: 8912164.
      Citations: 5     Fields:    Translation:AnimalsCells
    148. Lopez-Ribot JL, Cortlandt DA, Straus DC, Morrow KJ, Chaffin WL. Complex interaction between different proteinaceous components within the cell-wall structure of Candida albicans. Mycopathologia. 1995 Nov; 132(2):87-93. PMID: 8819831.
      Citations:    Fields:    Translation:AnimalsCells
    149. Casanova M, Lopez-Ribot JL, Martinez JP, Sentandreu R. Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques. Infect Immun. 1992 Nov; 60(11):4898-906. PMID: 1383159.
      Citations: 38     Fields:    Translation:AnimalsCells
    150. Casanova M, Lopez-Ribot JL, Monteagudo C, Llombart-Bosch A, Sentandreu R, Martinez JP. Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect Immun. 1992 Oct; 60(10):4221-9. PMID: 1398933.
      Citations: 47     Fields:    Translation:HumansAnimals
    151. Lopez-Ribot JL, Casanova M, Martinez JP, Sentandreu R. Characterization of cell wall proteins of yeast and hydrophobic mycelial cells of Candida albicans. Infect Immun. 1991 Jul; 59(7):2324-32. PMID: 2050401.
      Citations: 34     Fields:    Translation:AnimalsCells
    152. Martinez JP, Gil ML, Casanova M, Lopez-Ribot JL, Garcia De Lomas J, Sentandreu R. Wall mannoproteins in cells from colonial phenotypic variants of Candida albicans. J Gen Microbiol. 1990 Dec; 136(12):2421-32. PMID: 2079629.
      Citations: 18     Fields:    Translation:AnimalsCells
    153. Martinez JP, Lopez-Ribot JL, Gil ML, Sentandreu R, Ruiz-Herrera J. Inhibition of the dimorphic transition of Candida albicans by the ornithine decarboxylase inhibitor 1,4-diaminobutanone: alterations in the glycoprotein composition of the cell wall. J Gen Microbiol. 1990 Oct; 136(10):1937-43. PMID: 2269870.
      Citations: 14     Fields:    Translation:AnimalsCells
    Lopez-Ribot's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (412)
    Co-Authors (8)
    Similar People (60)
    Same Department Expand Description
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support